About the Company
Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health business segments. The Prescription Pharmaceuticals segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The Consumer Health segment offers branded and private-label animal health; and over-the-counter products. The company was founded in 1971 and is headquartered in Lake Forest, IL.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AKRX News
7th Circuit Lets Shareholder Intervene in Mootness Fees Spat
It seems to us that, as an investor in Akorn whose shares’ value was affected by the merger and the mootness fees, Frank has a claim in common with the main action; how could it be otherwise?” Judge ...
Attorneys’ Fees for Merger Disclosures to Get Objector’s Attack
Ted Frank, a frequent objector in class actions, may participate in two largely resolved suits for additional disclosures in drugmaker Akorn Inc.'s proxy documents for a merger with Fresenius Kabi AG ...
Seventh Circuit Decision Outlines Framework To Allow Courts To Evaluate Individual Mootness Fees in Merger Challenge Lawsuits
The U.S. Court of Appeals for the Seventh Circuit in Jorge Alcarez, et al. v. Akorn Inc., et al. 1 mapped out one means by which a court may evaluate mootness fees paid to individual shareholders ...
Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
Prestige Consumer Healthcare Inc.’s PBH brand-building strategy and growing strength in the e-commerce channel are tailwinds.
Should New Jersey consider a bottle deposit system to increase recycling?
The Association of New Jersey Recyclers fears a bottle bill would result in ever fewer people correctly disposing of their ...
Naloxone Market To Reach USD 2,478.6 Million By 2032 | DataHorizzon Research
The naloxone market size was valued at USD 1,073.5 Million in 2023 and is expected to reach a market size of USD 2,478.6 ...
Global Glaucoma Treatment Industry is expected to reach US$ 8 Billion by 2033, growing at a consistent 3.2% CAGR | According to FMI
The Global Glaucoma Treatment Industry is on track for continued growth, according to a recent market analysis by Future ...
Mouth Ulcers Treatment Market to Surpass USD 3.8 Billion by 2032, with a CAGR of 3.9% | Marketresearch.biz Report
Marketresearch.biz reports that the Mouth Ulcers Treatment Market size is expected to be worth around USD 3.8 Bn by 2032 from USD 2.6 Bn in 2023, growing at a CAGR of 3.9% during the forecast period ...
How to choose a charcoal grill, according to grill-masters
Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. Charcoal grills are as nostalgic as they are simple, yet they’ve come ...
Loading the latest forecasts...